{"hands_on_practices": [{"introduction": "Effective sRNA design hinges on a fundamental trade-off: maximizing on-target repression while minimizing off-target effects. This exercise challenges you to formalize this design principle as a constrained optimization problem [@problem_id:2774066]. By modeling binding affinity as a function of the seed region's GC content, you will learn to navigate the delicate balance between binding strength and specificity to find an optimal design, a core skill in quantitative synthetic biology.", "problem": "You are designing a small RNA (sRNA) seed region to repress a specific messenger RNA (mRNA) target in a bacterium using base-pairing interactions. The seed region has length $n$, and its guanine-cytosine (GC) fraction $x \\in [0,1]$ is the sole design variable. Assume the following scientifically justified bases:\n\n- Central Dogma and thermodynamic control: sRNA binds its mRNA target by Watson-Crick base-pairing to form an sRNA:mRNA duplex, with an equilibrium association constant $K$ that obeys $K = \\exp(-\\beta \\Delta G)$, where $\\beta = 1/(k_{B}T)$ and $\\Delta G$ is the standard-state binding free energy.\n- Langmuir occupancy for repression: the fractional occupancy of a site at free sRNA concentration $c$ is $\\theta = \\dfrac{cK}{1 + cK}$.\n- Nearest-neighbor linearization for the seed: the on-target free energy is modeled as\n$$\n\\Delta G_{\\mathrm{on}}(x) = \\Delta G_{\\mathrm{init}} + n\\left[(1-x)g_{\\mathrm{AU}} + x g_{\\mathrm{GC}}\\right],\n$$\nwith $g_{\\mathrm{GC}} < g_{\\mathrm{AU}} < 0$ representing average per-pair contributions for guanine-cytosine and adenine-uracil pairs, and $\\Delta G_{\\mathrm{init}}$ an initiation term.\n- Off-target model with one seed mismatch: consider a representative off-target that contains a single mismatch at a uniformly random position within the seed. The penalty for disrupting a guanine-cytosine pair is $\\Delta_g > 0$ and for disrupting an adenine-uracil pair is $\\Delta_a > 0$. The expected mismatch penalty is then $\\Delta\\Delta G_{\\mathrm{mm}}(x) = x\\,\\Delta_g + (1-x)\\,\\Delta_a$, so that\n$$\n\\Delta G_{\\mathrm{off}}(x) = \\Delta G_{\\mathrm{on}}(x) + \\Delta\\Delta G_{\\mathrm{mm}}(x).\n$$\n\nFormulate and solve the optimization problem that maximizes on-target occupancy $\\theta_{\\mathrm{on}}(x)$ subject to an upper bound on off-target occupancy $\\theta_{\\mathrm{off}}(x) \\le \\theta_{\\mathrm{thr}}$, given the following parameters, all at temperature $T$:\n- Seed length $n = 8$,\n- Per-pair free energies $g_{\\mathrm{GC}} = -2.0\\,\\mathrm{kcal\\,mol^{-1}}$ and $g_{\\mathrm{AU}} = -1.0\\,\\mathrm{kcal\\,mol^{-1}}$,\n- Initiation term $\\Delta G_{\\mathrm{init}} = +4.0\\,\\mathrm{kcal\\,mol^{-1}}$,\n- Mismatch penalties $\\Delta_g = +3.0\\,\\mathrm{kcal\\,mol^{-1}}$ and $\\Delta_a = +2.0\\,\\mathrm{kcal\\,mol^{-1}}$,\n- Free sRNA concentration $c = 100\\,\\mathrm{nM}$,\n- Off-target occupancy threshold $\\theta_{\\mathrm{thr}} = 0.05$,\n- Boltzmann constant $k_B = 1.9872 \\times 10^{-3}\\,\\mathrm{kcal\\,mol^{-1}\\,K^{-1}}$ and temperature $T = 310\\,\\mathrm{K}$.\n\nExplicitly:\n- Write the optimization problem in terms of $x$, $\\theta_{\\mathrm{on}}(x)$, $\\theta_{\\mathrm{off}}(x)$, and the parameters above.\n- Solve it to obtain the optimal GC fraction $x^{\\star}$.\n- Express your final answer as the value of $x^{\\star}$, rounded to four significant figures, and report it as a dimensionless fraction in the interval $[0,1]$.", "solution": "The problem as stated constitutes a valid, well-posed optimization problem grounded in the principles of biophysical chemistry. We shall proceed to its formal solution.\n\nThe objective is to maximize the on-target occupancy, $\\theta_{\\mathrm{on}}(x)$, subject to an upper bound on the off-target occupancy, $\\theta_{\\mathrm{off}}(x)$. The problem can be formally stated as:\n$$\n\\underset{x \\in [0,1]}{\\text{maximize}} \\quad \\theta_{\\mathrm{on}}(x)\n$$\n$$\n\\text{subject to} \\quad \\theta_{\\mathrm{off}}(x) \\le \\theta_{\\mathrm{thr}}\n$$\n\nFirst, we must express the objective and constraint functions in terms of the design variable $x$, the GC-fraction. The fractional occupancy $\\theta$ for a given species (on- or off-target) is given by $\\theta = \\frac{cK}{1 + cK}$, where $K = \\exp\\left(-\\frac{\\Delta G}{k_B T}\\right)$.\n\nThe on-target binding free energy is:\n$$\n\\Delta G_{\\mathrm{on}}(x) = \\Delta G_{\\mathrm{init}} + n\\left[(1-x)g_{\\mathrm{AU}} + x g_{\\mathrm{GC}}\\right]\n$$\nRearranging this into a linear function of $x$:\n$$\n\\Delta G_{\\mathrm{on}}(x) = (\\Delta G_{\\mathrm{init}} + n g_{\\mathrm{AU}}) + n x (g_{\\mathrm{GC}} - g_{\\mathrm{AU}})\n$$\nGiven the parameters $g_{\\mathrm{GC}} = -2.0\\,\\mathrm{kcal\\,mol^{-1}}$ and $g_{\\mathrm{AU}} = -1.0\\,\\mathrm{kcal\\,mol^{-1}}$, the coefficient of $x$, which is $n(g_{\\mathrm{GC}} - g_{\\mathrm{AU}})$, is negative. Therefore, $\\Delta G_{\\mathrm{on}}(x)$ is a monotonically decreasing function of $x$. A lower free energy corresponds to stronger binding. The association constant is $K_{\\mathrm{on}}(x) = \\exp(-\\Delta G_{\\mathrm{on}}(x)/(k_B T))$, which is a monotonically increasing function of $x$. The occupancy, $\\theta_{\\mathrm{on}}(x) = \\frac{cK_{\\mathrm{on}}(x)}{1 + cK_{\\mathrm{on}}(x)}$, is a monotonically increasing function of $K_{\\mathrm{on}}(x)$. Consequently, the objective function $\\theta_{\\mathrm{on}}(x)$ is a monotonically increasing function of $x$. To maximize $\\theta_{\\mathrm{on}}(x)$, we must choose the largest possible value of $x$.\n\nNext, we analyze the constraint function, $\\theta_{\\mathrm{off}}(x)$. The off-target binding free energy is:\n$$\n\\Delta G_{\\mathrm{off}}(x) = \\Delta G_{\\mathrm{on}}(x) + x\\,\\Delta_g + (1-x)\\,\\Delta_a\n$$\nSubstituting the expression for $\\Delta G_{\\mathrm{on}}(x)$ and rearranging:\n$$\n\\Delta G_{\\mathrm{off}}(x) = (\\Delta G_{\\mathrm{init}} + n g_{\\mathrm{AU}}) + n x (g_{\\mathrm{GC}} - g_{\\mathrm{AU}}) + x\\Delta_g + \\Delta_a - x\\Delta_a\n$$\n$$\n\\Delta G_{\\mathrm{off}}(x) = (\\Delta G_{\\mathrm{init}} + n g_{\\mathrm{AU}} + \\Delta_a) + x \\left[n(g_{\\mathrm{GC}} - g_{\\mathrm{AU}}) + (\\Delta_g - \\Delta_a)\\right]\n$$\nLet us evaluate the coefficient of $x$:\n$n(g_{\\mathrm{GC}} - g_{\\mathrm{AU}}) + (\\Delta_g - \\Delta_a) = 8(-2.0 - (-1.0)) + (3.0 - 2.0) = 8(-1.0) + 1.0 = -7.0\\,\\mathrm{kcal\\,mol^{-1}}$.\nSince this coefficient is also negative, $\\Delta G_{\\mathrm{off}}(x)$ is a monotonically decreasing function of $x$. By the same logic as for the on-target case, the off-target occupancy $\\theta_{\\mathrm{off}}(x)$ is a monotonically increasing function of $x$.\n\nThe optimization problem is to maximize an increasing function $\\theta_{\\mathrm{on}}(x)$ subject to the constraint $\\theta_{\\mathrm{off}}(x) \\le \\theta_{\\mathrm{thr}}$, where $\\theta_{\\mathrm{off}}(x)$ is also an increasing function. This implies we should choose the largest value of $x$ that still satisfies the constraint. The optimal value, $x^{\\star}$, will be found when the constraint is active, that is, at equality:\n$$\n\\theta_{\\mathrm{off}}(x^{\\star}) = \\theta_{\\mathrm{thr}}\n$$\nWe must solve this equation for $x^{\\star}$. First, we solve for the binding energy $\\Delta G_{\\mathrm{off}}(x^{\\star})$:\n$$\n\\frac{c K_{\\mathrm{off}}(x^{\\star})}{1 + c K_{\\mathrm{off}}(x^{\\star})} = \\theta_{\\mathrm{thr}} \\implies c K_{\\mathrm{off}}(x^{\\star}) = \\theta_{\\mathrm{thr}}(1 + c K_{\\mathrm{off}}(x^{\\star})) \\implies K_{\\mathrm{off}}(x^{\\star}) = \\frac{\\theta_{\\mathrm{thr}}}{c(1-\\theta_{\\mathrm{thr}})}\n$$\nTaking the natural logarithm and using $K = \\exp(-\\Delta G / (k_B T))$:\n$$\n-\\frac{\\Delta G_{\\mathrm{off}}(x^{\\star})}{k_B T} = \\ln\\left(\\frac{\\theta_{\\mathrm{thr}}}{c(1-\\theta_{\\mathrm{thr}})}\\right)\n$$\n$$\n\\Delta G_{\\mathrm{off}}(x^{\\star}) = -k_B T \\ln\\left(\\frac{\\theta_{\\mathrm{thr}}}{c(1-\\theta_{\\mathrm{thr}})}\\right)\n$$\nNow, we substitute the linear expression for $\\Delta G_{\\mathrm{off}}(x)$:\n$$\n(\\Delta G_{\\mathrm{init}} + n g_{\\mathrm{AU}} + \\Delta_a) + x^{\\star} \\left[n(g_{\\mathrm{GC}} - g_{\\mathrm{AU}}) + (\\Delta_g - \\Delta_a)\\right] = -k_B T \\ln\\left(\\frac{\\theta_{\\mathrm{thr}}}{c(1-\\theta_{\\mathrm{thr}})}\\right)\n$$\nSolving for $x^{\\star}$:\n$$\nx^{\\star} = \\frac{-k_B T \\ln\\left(\\frac{\\theta_{\\mathrm{thr}}}{c(1-\\theta_{\\mathrm{thr}})}\\right) - (\\Delta G_{\\mathrm{init}} + n g_{\\mathrm{AU}} + \\Delta_a)}{n(g_{\\mathrm{GC}} - g_{\\mathrm{AU}}) + \\Delta_g - \\Delta_a}\n$$\nNow, we substitute the given numerical values. The thermal energy is $k_B T = (1.9872 \\times 10^{-3}\\,\\mathrm{kcal\\,mol^{-1}\\,K^{-1}}) \\times (310\\,\\mathrm{K}) \\approx 0.616032\\,\\mathrm{kcal\\,mol^{-1}}$. The concentration must be in molar units to be consistent with the standard state for free energies, so $c = 100\\,\\mathrm{nM} = 1.0 \\times 10^{-7}\\,\\mathrm{M}$.\nThe numerator terms are:\n$$\n\\text{Term 1 (Target } \\Delta G_{\\mathrm{off}}): -0.616032 \\times \\ln\\left(\\frac{0.05}{(1.0 \\times 10^{-7})(1-0.05)}\\right) = -0.616032 \\times \\ln\\left(\\frac{0.05}{0.95 \\times 10^{-7}}\\right)\n$$\n$$\n\\approx -0.616032 \\times \\ln(5.263158 \\times 10^5) \\approx -0.616032 \\times 13.173656 \\approx -8.115456\\,\\mathrm{kcal\\,mol^{-1}}\n$$\n$$\n\\text{Term 2 (Constant part): } \\Delta G_{\\mathrm{init}} + n g_{\\mathrm{AU}} + \\Delta_a = 4.0 + 8(-1.0) + 2.0 = -2.0\\,\\mathrm{kcal\\,mol^{-1}}\n$$\nThe denominator is:\n$$\nn(g_{\\mathrm{GC}} - g_{\\mathrm{AU}}) + (\\Delta_g - \\Delta_a) = 8(-2.0 - (-1.0)) + (3.0-2.0) = -8.0 + 1.0 = -7.0\\,\\mathrm{kcal\\,mol^{-1}}\n$$\nSubstituting these values back into the expression for $x^{\\star}$:\n$$\nx^{\\star} = \\frac{-8.115456 - (-2.0)}{-7.0} = \\frac{-6.115456}{-7.0} \\approx 0.8736366\n$$\nThe problem requires the answer to be rounded to four significant figures. This yields $x^{\\star} = 0.8736$. This value is in the valid range $[0, 1]$, confirming the approach.\nThe final optimal GC fraction is $0.8736$.", "answer": "$$\\boxed{0.8736}$$", "id": "2774066"}, {"introduction": "An engineered sRNA does not operate in isolation; it must compete for binding with a vast landscape of endogenous transcripts and potentially other synthetic components. This practice explores the critical concept of titration, where the free concentration of an sRNA is determined by its partitioning across multiple binding pools [@problem_id:2774048]. By solving the mass-balance equations for an sRNA in the presence of an engineered sponge and a complex transcriptome background, you will quantify how resource competition dictates regulatory outcomes.", "problem": "In a bacterial synthetic biology context, consider a small ribonucleic acid (sRNA) that regulates messenger RNA (mRNA) targets by seed-region base pairing. The sRNA has a seed of length $\\ell = 7$ nucleotides with sequence $5'\\text{-GGCACAU-}3'$. A synthetic sRNA sponge is introduced that carries $N_{\\text{sp}}$ independent binding sites whose sequences are designed to be antisense to the seed except for a single mismatch within the seed. The cell also contains a background of accessible, independent $7$-nucleotide windows across the transcriptome that can weakly bind the sRNA seed by chance complementarity. Assume the following:\n- Total sRNA concentration is $[S]_{\\text{tot}} = 50\\,\\mathrm{nM}$.\n- Total concentration of sponge binding sites is $[X_{\\text{sp}}]_{\\text{tot}} = 30\\,\\mathrm{nM}$, and each sponge site has exactly one mismatch in the $7$-nt seed region relative to perfect antisense complementarity.\n- The transcriptome background has independent nucleotide composition with probabilities $p_{\\mathrm{A}} = 0.3$, $p_{\\mathrm{U}} = 0.3$, $p_{\\mathrm{G}} = 0.2$, $p_{\\mathrm{C}} = 0.2$. The total concentration of accessible $7$-nt windows is $[W]_{\\text{tot}} = 10\\,\\mu\\mathrm{M}$. Treat each window as an independent, single sRNA binding site.\n- Binding equilibrium follows the law of mass action. The dissociation constant for seed binding depends only on the number of seed matches $m$ as $K_{d}(m) = K_{0}\\,\\alpha^{(\\ell - m)}$, with $K_{0} = 1\\,\\mathrm{nM}$ and $\\alpha = 10$. Thus, perfect seed matches ($m=7$) have $K_{d}(7) = 1\\,\\mathrm{nM}$ and single-mismatch seeds ($m=6$) have $K_{d}(6) = 10\\,\\mathrm{nM}$.\n- Assume background windows with $m \\leq 5$ matches are negligibly weak and can be ignored. Assume independent binding, no steric hindrance, and that only seed pairing within the $7$-nt window contributes to affinity.\n\nTasks:\n1. Using the specified transcriptome base composition and the sRNA seed sequence, compute the expected concentrations of background sites that are perfect seed complements, $[B_{7}]$, and those with exactly one seed mismatch, $[B_{6}]$, within the accessible windows $[W]_{\\text{tot}}$. Assume independence of nucleotide occurrences across positions in the $7$-nt window.\n2. Let $[S]_{\\text{free}}$ denote the free sRNA concentration at equilibrium. Write the mass balance for sRNA over free and bound pools across the sponge sites, background perfect sites, and background single-mismatch sites, and solve for $[S]_{\\text{free}}$.\n3. From the equilibrium solution, compute the fraction of total sRNA bound to the sponge, defined as $\\phi_{\\text{sp}} = \\dfrac{[X_{\\text{sp}}]_{\\text{tot}}\\,\\dfrac{[S]_{\\text{free}}}{K_{d}(6)+[S]_{\\text{free}}}}{[S]_{\\text{tot}}}$.\n\nRound your final numerical answer for $\\phi_{\\text{sp}}$ to three significant figures and express it as a unitless decimal.", "solution": "The problem requires a quantitative analysis of sRNA-target interactions in a synthetic biological system, accounting for both engineered sponge decoys and off-target interactions with the background transcriptome. The solution is executed in three stages as requested.\n\nFirst, we determine the concentrations of background binding sites. The sRNA seed has a length $\\ell = 7$ and sequence $5'\\text{-GGCACAU-}3'$. A perfectly complementary binding site on an mRNA strand would pair according to Watson-Crick rules (G-C, A-U). The sRNA sequence is specified in the $5' \\to 3'$ direction. For pairing, the target mRNA must be oriented antiparallel, i.e., in the $3' \\to 5'$ direction relative to the sRNA.\n$$\n\\text{sRNA: } 5'-\\text{GGCACAU}-3' \\\\\n\\text{mRNA: } 3'-\\text{CCGUGUA}-5'\n$$\nThe conventional representation of a nucleic acid sequence is $5' \\to 3'$. Thus, the perfectly complementary target sequence, which we denote as the $B_7$ sequence, is $5'\\text{-AUGUGCC-}3'$.\n\nThe problem provides the independent nucleotide probabilities in the transcriptome: $p_{\\mathrm{A}} = 0.3$, $p_{\\mathrm{U}} = 0.3$, $p_{\\mathrm{G}} = 0.2$, and $p_{\\mathrm{C}} = 0.2$. The $B_7$ sequence ($5'\\text{-AUGUGCC-}3'$) contains one A, two U's, two G's, and two C's. The probability of any given $7$-nucleotide window matching this sequence exactly, $P(B_7)$, is the product of the probabilities of finding the specific nucleotide at each position:\n$$\nP(B_7) = p_{\\mathrm{A}}^{1} \\cdot p_{\\mathrm{U}}^{2} \\cdot p_{\\mathrm{G}}^{2} \\cdot p_{\\mathrm{C}}^{2} = (0.3)^{1}(0.3)^{2}(0.2)^{2}(0.2)^{2} = (0.3)^{3}(0.2)^{4} = (0.027)(0.0016) = 4.32 \\times 10^{-5}\n$$\nThe total concentration of accessible $7$-nt windows is given as $[W]_{\\text{tot}} = 10\\,\\mu\\mathrm{M} = 10000\\,\\mathrm{nM}$. The expected concentration of perfect match background sites, $[B_7]$, is:\n$$\n[B_7] = P(B_7) \\times [W]_{\\text{tot}} = (4.32 \\times 10^{-5}) \\times (10000\\,\\mathrm{nM}) = 0.432\\,\\mathrm{nM}\n$$\nNext, we calculate the concentration of background sites with exactly one mismatch, $[B_6]$. The probability of a single mismatch, $P(B_6)$, is the sum of probabilities of all sequences that differ from the perfect complement at exactly one position. This can be calculated by summing, over all positions $i=1, \\dots, 7$, the probability of a mismatch at position $i$ while all other positions $j \\neq i$ are correct. Let $w_i$ be the nucleotide at position $i$ in the perfect target sequence. The probability of having a correct nucleotide is $p_{w_i}$, and the probability of a mismatch is $(1 - p_{w_i})$. The probability of having a mismatch at position $i$ and matches everywhere else is $P(\\text{mismatch at } i) = (1-p_{w_i}) \\prod_{j \\neq i} p_{w_j}$. This can be rewritten relative to $P(B_7) = \\prod_{k=1}^7 p_{w_k}$ as:\n$$\nP(\\text{mismatch at } i) = (1-p_{w_i}) \\frac{P(B_7)}{p_{w_i}} = P(B_7) \\left( \\frac{1-p_{w_i}}{p_{w_i}} \\right)\n$$\nThe total probability $P(B_6)$ is the sum over all possible single-mismatch positions:\n$$\nP(B_6) = \\sum_{i=1}^{7} P(\\text{mismatch at } i) = P(B_7) \\sum_{i=1}^{7} \\left( \\frac{1-p_{w_i}}{p_{w_i}} \\right)\n$$\nThe perfect target sequence $5'\\text{-AUGUGCC-}3'$ has nucleotides with these probabilities: position 1 (A, $p=0.3$), 2 (U, $p=0.3$), 3 (G, $p=0.2$), 4 (U, $p=0.3$), 5 (G, $p=0.2$), 6 (C, $p=0.2$), 7 (C, $p=0.2$). There are 3 positions with $p=0.3$ and 4 positions with $p=0.2$. The sum is:\n$$\n\\sum_{i=1}^{7} \\left( \\frac{1-p_{w_i}}{p_{w_i}} \\right) = 3 \\times \\left( \\frac{1-0.3}{0.3} \\right) + 4 \\times \\left( \\frac{1-0.2}{0.2} \\right) = 3 \\times \\left( \\frac{0.7}{0.3} \\right) + 4 \\times \\left( \\frac{0.8}{0.2} \\right) = 3 \\times \\frac{7}{3} + 4 \\times 4 = 7 + 16 = 23\n$$\nThus, $P(B_6) = 23 \\times P(B_7) = 23 \\times 4.32 \\times 10^{-5} = 9.936 \\times 10^{-4}$. The concentration $[B_6]$ is:\n$$\n[B_6] = P(B_6) \\times [W]_{\\text{tot}} = (9.936 \\times 10^{-4}) \\times (10000\\,\\mathrm{nM}) = 9.936\\,\\mathrm{nM}\n$$\n\nSecond, we formulate the mass balance for the total sRNA concentration, $[S]_{\\text{tot}}$. The total sRNA is distributed among free sRNA, $[S]_{\\text{free}}$, and sRNA bound to the three types of sites considered: sponge sites $[S:X_{\\text{sp}}]$, background perfect sites $[S:B_7]$, and background single-mismatch sites $[S:B_6]$.\n$$\n[S]_{\\text{tot}} = [S]_{\\text{free}} + [S:X_{\\text{sp}}] + [S:B_7] + [S:B_6]\n$$\nThe concentration of bound sRNA for a generic pool of sites $Y$ is given by the law of mass action: $[S:Y] = [Y]_{\\text{tot}} \\frac{[S]_{\\text{free}}}{K_d + [S]_{\\text{free}}}$. We apply this to each sRNA-bound complex. Let $S_f = [S]_{\\text{free}}$.\nThe dissociation constants are $K_d(m) = K_0 \\alpha^{(\\ell-m)}$ with $K_0=1\\,\\mathrm{nM}$, $\\alpha=10$, $\\ell=7$.\n- For sponge sites ($m=6$ matches): $K_d(6) = 1 \\times 10^{(7-6)} = 10\\,\\mathrm{nM}$.\n- For $B_7$ sites ($m=7$ matches): $K_d(7) = 1 \\times 10^{(7-7)} = 1\\,\\mathrm{nM}$.\n- For $B_6$ sites ($m=6$ matches): $K_d(6) = 10\\,\\mathrm{nM}$.\nThe mass balance equation becomes:\n$$\n[S]_{\\text{tot}} = S_f + [X_{\\text{sp}}]_{\\text{tot}} \\frac{S_f}{K_d(6) + S_f} + [B_7] \\frac{S_f}{K_d(7) + S_f} + [B_6] \\frac{S_f}{K_d(6) + S_f}\n$$\nWe can group the terms with the same dissociation constant:\n$$\n[S]_{\\text{tot}} = S_f + \\left( [X_{\\text{sp}}]_{\\text{tot}} + [B_6] \\right) \\frac{S_f}{K_d(6) + S_f} + [B_7] \\frac{S_f}{K_d(7) + S_f}\n$$\nSubstituting the known values: $[S]_{\\text{tot}} = 50\\,\\mathrm{nM}$, $[X_{\\text{sp}}]_{\\text{tot}} = 30\\,\\mathrm{nM}$, $[B_7] = 0.432\\,\\mathrm{nM}$, and $[B_6] = 9.936\\,\\mathrm{nM}$.\n$$\n50 = S_f + (30 + 9.936) \\frac{S_f}{10 + S_f} + 0.432 \\frac{S_f}{1 + S_f}\n$$\n$$\n50 = S_f + 39.936 \\frac{S_f}{10 + S_f} + 0.432 \\frac{S_f}{1 + S_f}\n$$\nThis is a non-linear equation for $S_f$. Multiplying by the denominators $(10+S_f)(1+S_f)$ leads to a cubic polynomial:\n$S_f^3 + 1.368 S_f^2 - 495.744 S_f - 500 = 0$.\nThe physically meaningful solution must be a positive real root. We solve this equation numerically. An iterative search reveals that the function $g(S_f) = S_f + 39.936 \\frac{S_f}{10 + S_f} + 0.432 \\frac{S_f}{1 + S_f}$ equals $50$ for $S_f \\approx 22.094$.\nUsing this value:\n$g(22.094) = 22.094 + 39.936 \\frac{22.094}{10 + 22.094} + 0.432 \\frac{22.094}{1 + 22.094} \\approx 22.094 + 27.495 + 0.413 = 49.999 \\approx 50$.\nSo, the equilibrium free sRNA concentration is $[S]_{\\text{free}} = S_f = 22.094\\,\\mathrm{nM}$.\n\nThird, we compute the fraction of total sRNA bound to the sponge, $\\phi_{\\text{sp}}$. This is the concentration of sRNA bound to the sponge divided by the total sRNA concentration.\n$$\n\\phi_{\\text{sp}} = \\frac{[S:X_{\\text{sp}}]}{[S]_{\\text{tot}}} = \\frac{[X_{\\text{sp}}]_{\\text{tot}}\\,\\dfrac{S_f}{K_{d}(6)+S_f}}{[S]_{\\text{tot}}}\n$$\nSubstituting the numerical values:\n$$\n\\phi_{\\text{sp}} = \\frac{30\\,\\mathrm{nM} \\times \\dfrac{22.094\\,\\mathrm{nM}}{10\\,\\mathrm{nM} + 22.094\\,\\mathrm{nM}}}{50\\,\\mathrm{nM}}\n$$\n$$\n\\phi_{\\text{sp}} = \\frac{30 \\times \\dfrac{22.094}{32.094}}{50} = \\frac{30 \\times 0.68841}{50} = \\frac{20.6523}{50} = 0.413046\n$$\nRounding to three significant figures, the fraction is $0.413$.", "answer": "$$\\boxed{0.413}$$", "id": "2774048"}, {"introduction": "The function of an sRNA-based circuit is contingent upon the reliable production of the sRNA itself. This exercise delves into the biogenesis of small RNAs, examining how alternative, non-canonical pathways can become active when the primary processing machinery is compromised [@problem_id:2774093]. You will apply a simplified thermodynamic and kinetic model to predict the relative contributions of these compensatory routes, gaining insight into the robustness and plasticity of gene regulatory networks.", "problem": "A mammalian cell line has a knockout of the Microprocessor RNase III enzyme Drosha, eliminating canonical primary microRNA processing. Nevertheless, small RNA-mediated gene control can still arise via alternative biogenesis routes that do not require Drosha. Consider three Drosha-independent routes that can generate small RNAs capable of loading into the RNA-Induced Silencing Complex (RISC): (1) splicing-dependent intronic microRNA mimics (mirtrons), which rely on the spliceosome and Dicer; (2) transfer RNA-derived fragments (tRFs) generated by ribonuclease Z (ELAC2) and Angiogenin; and (3) endogenous small interfering RNAs (endo-siRNAs) arising from sense-antisense transcript duplexes processed by Dicer. Assume Argonaute availability and post-loading stability are comparable across routes so that they do not bias relative likelihoods.\n\nYou will use a simple thermodynamic-kinetic model grounded in the following base principles:\n- In the unsaturated, first-order regime of enzyme action (a low-substrate limit of Michaelis–Menten kinetics), an overall production rate scales linearly with the effective availability of the limiting enzyme(s).\n- The probability of surmounting a dominant, effective free-energy barrier for producing a competent precursor scales with a Boltzmann factor, so that the microscopic attempt-weight for that route is proportional to $\\exp(-\\Delta G_{i}/(RT))$, where $\\Delta G_{i}$ is an effective free-energy penalty for forming the rate-limiting productive intermediate of route $i$, $R$ is the gas constant, and $T$ is the absolute temperature.\n\nModel the unnormalized production propensity of route $i$ as $w_{i} \\propto \\alpha_{i}\\exp(-\\Delta G_{i}/(RT))$, where $\\alpha_{i}$ is a dimensionless composite factor capturing the effective availability of required enzymes for route $i$. Normalize to obtain $p_{i} = w_{i}/\\sum_{j} w_{j}$ as the probability that a randomly observed functional small RNA originates from route $i$ in steady state.\n\nFor a Drosha knockout at physiological temperature, take $T = 310\\,\\mathrm{K}$ and $R = 1.987 \\times 10^{-3}\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}\\,\\mathrm{K}^{-1}$. Use the following effective parameters, which summarize rate-limiting formation penalties and enzyme availability in typical proliferating mammalian cells:\n- Mirtrons: $\\Delta G_{1} = 3.0\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}$ and $\\alpha_{1} = 1.0$ (spliceosome, lariat debranching enzyme, and Dicer are abundant).\n- tRNA-derived fragments: $\\Delta G_{2} = 5.5\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}$ and $\\alpha_{2} = 0.30$ (limited by Angiogenin and ribonuclease Z activities).\n- Endogenous siRNAs: $\\Delta G_{3} = 7.0\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}$ and $\\alpha_{3} = 0.20$ (limited by the availability of sufficiently long double-stranded RNA and Dicer access).\n\nStarting only from the base principles above and the provided parameters, derive the normalized probabilities $p_{i}$ and the ranking of the three routes by likelihood. Then, report the probability that a functional small RNA arises via the mirtron route, $p_{1}$, expressed as a decimal fraction. Round your final numerical answer to four significant figures. No unit should be attached to the final number.", "solution": "The supplied problem has been subjected to validation and is deemed scientifically grounded, well-posed, and self-contained. It presents a simplified biophysical model based on established principles of enzyme kinetics and statistical mechanics (Boltzmann distribution) to analyze a relevant biological scenario—the relative contributions of different small RNA biogenesis pathways in a specific genetic context (Drosha knockout). All necessary parameters and definitions are provided, allowing for a unique and meaningful solution. There are no logical contradictions, factual inaccuracies, or ambiguities that would invalidate the problem. We may therefore proceed with the derivation.\n\nThe problem requires us to calculate the probability, $p_i$, that a functional small RNA originates from one of three Drosha-independent biogenesis routes. The unnormalized production propensity for each route, $w_i$, is given by the model:\n$$w_{i} = C \\cdot \\alpha_{i} \\exp\\left(-\\frac{\\Delta G_{i}}{RT}\\right)$$\nwhere $C$ is a constant of proportionality that can be set to $1$ without loss of generality, as it will cancel during normalization. The parameters are:\n- $\\alpha_{i}$: a dimensionless factor for effective enzyme availability.\n- $\\Delta G_{i}$: the effective free-energy penalty for the rate-limiting step.\n- $R$: the gas constant, given as $1.987 \\times 10^{-3}\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}\\,\\mathrm{K}^{-1}$.\n- $T$: the absolute temperature, given as $310\\,\\mathrm{K}$.\n\nFirst, we compute the product $RT$, which represents the thermal energy scale in the appropriate units:\n$$RT = (1.987 \\times 10^{-3}\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}\\,\\mathrm{K}^{-1}) \\times (310\\,\\mathrm{K}) = 0.61597\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}$$\n\nNow, we will calculate the unnormalized propensity, $w_i$, for each of the three routes using the provided parameters.\n\n1.  **Route 1: Mirtrons**\n    The parameters are $\\Delta G_{1} = 3.0\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}$ and $\\alpha_{1} = 1.0$.\n    The dimensionless exponent is:\n    $$\\frac{\\Delta G_{1}}{RT} = \\frac{3.0\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}}{0.61597\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}} \\approx 4.870367$$\n    The propensity $w_{1}$ is:\n    $$w_{1} = \\alpha_{1} \\exp\\left(-\\frac{\\Delta G_{1}}{RT}\\right) = 1.0 \\times \\exp(-4.870367) \\approx 0.0076706$$\n\n2.  **Route 2: tRNA-derived fragments (tRFs)**\n    The parameters are $\\Delta G_{2} = 5.5\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}$ and $\\alpha_{2} = 0.30$.\n    The dimensionless exponent is:\n    $$\\frac{\\Delta G_{2}}{RT} = \\frac{5.5\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}}{0.61597\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}} \\approx 8.928990$$\n    The propensity $w_{2}$ is:\n    $$w_{2} = \\alpha_{2} \\exp\\left(-\\frac{\\Delta G_{2}}{RT}\\right) = 0.30 \\times \\exp(-8.928990) \\approx 0.30 \\times 0.0001325 = 0.00003975$$\n\n3.  **Route 3: Endogenous siRNAs (endo-siRNAs)**\n    The parameters are $\\Delta G_{3} = 7.0\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}$ and $\\alpha_{3} = 0.20$.\n    The dimensionless exponent is:\n    $$\\frac{\\Delta G_{3}}{RT} = \\frac{7.0\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}}{0.61597\\,\\mathrm{kcal}\\,\\mathrm{mol}^{-1}} \\approx 11.364352$$\n    The propensity $w_{3}$ is:\n    $$w_{3} = \\alpha_{3} \\exp\\left(-\\frac{\\Delta G_{3}}{RT}\\right) = 0.20 \\times \\exp(-11.364352) \\approx 0.20 \\times 0.00001160 = 0.00000232$$\n\nThe normalized probability for each route, $p_i$, is found by dividing its propensity $w_i$ by the sum of all propensities, $W_{\\text{total}} = \\sum_{j=1}^{3} w_{j}$.\n$$W_{\\text{total}} = w_{1} + w_{2} + w_{3} \\approx 0.0076706 + 0.00003975 + 0.00000232 = 0.00771267$$\n\nNow we compute the individual probabilities:\n$$p_{1} = \\frac{w_{1}}{W_{\\text{total}}} = \\frac{0.0076706}{0.00771267} \\approx 0.994545$$\n$$p_{2} = \\frac{w_{2}}{W_{\\text{total}}} = \\frac{0.00003975}{0.00771267} \\approx 0.005153$$\n$$p_{3} = \\frac{w_{3}}{W_{\\text{total}}} = \\frac{0.00000232}{0.00771267} \\approx 0.000301$$\n\nThe ranking of the routes by likelihood of producing a functional small RNA is determined by the magnitudes of their probabilities. Since $w_1 > w_2 > w_3$, it follows that $p_1 > p_2 > p_3$. The ranking is:\n$1$. Mirtron route\n$2$. tRNA-derived fragment route\n$3$. Endogenous siRNA route\n\nThe problem specifically asks for the probability of the mirtron route, $p_{1}$, expressed as a decimal fraction rounded to four significant figures.\nFrom our calculation, $p_1 \\approx 0.994545$. Rounding to four significant figures yields $0.9945$.", "answer": "$$\\boxed{0.9945}$$", "id": "2774093"}]}